[EN] SILYL-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES [FR] COMPOSÉS HÉTÉROCYCLIQUES CONTENANT UN SILYLE ET MÉTHODES D'UTILISATION DESDITS COMPOSÉS POUR TRAITER LES MALADIES VIRALES
[EN] SILYL-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES [FR] COMPOSÉS HÉTÉROCYCLIQUES CONTENANT UN SILYLE ET MÉTHODES D'UTILISATION DESDITS COMPOSÉS POUR TRAITER LES MALADIES VIRALES
Despite the utility of 9-silafluorenes as functional materials and as building blocks, methods for efficient functionalization of their backbone are rare, probably because of the presence of easily cleavable C–Si bonds. Although controlling the regioselectivity of iridium-catalyzed direct borylation of C–H bonds is difficult, we found that bromination and nitration of 2-methoxy-9-silafluorene under
Silole‐containing polymers for high‐efficiency polymer solar cells
作者:Jinsheng Song、Chun Du、Cuihong Li、Zhishan Bo
DOI:10.1002/pola.24870
日期:2011.10
Silole‐containing conjugated polymers (P1 and P2) carrying methyl and octyl substituents, respectively, on the silicon atom were synthesized by Suzuki polycondensation. They show strong absorption in the region of 300–700 nm with a band gap of about 1.9 eV. The two silole‐containing conjugated polymers were used to fabricate polymersolarcells by blending with PC61BM and PC71BM as the active layer
Alkoxy highly edge-decorated polycylic aromatic hydrocarbons (PAHs) have been formed. Oxidative cross coupling of phenols constructs frameworks without any need for the prefunctionalization required by conventional methods. Moreover, smaller optical gaps can be achieved relative to systems of similar size.
[EN] SILYL-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES CONTENANT UN SILYLE ET MÉTHODES D'UTILISATION DESDITS COMPOSÉS POUR TRAITER LES MALADIES VIRALES
申请人:MERCK SHARP & DOHME
公开号:WO2013039876A1
公开(公告)日:2013-03-21
The present invention relates to novel Silyl-Containing Heterocyclic Compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, B, C, D, E, F and L are as defined herein. The present invention also relates to compositions comprising at least one Silyl-Containing Heterocyclic Compound, and methods of using the Silyl-Containing Heterocyclic Compounds for treating or preventing HCV infection in a patient.